Introduction of the new guidelines on treatment of drug-resistant tuberculosis, and the face-to-face meeting of the Green Light Committee for the WHO European Region (rGLC/Europe)

19–21 February 2019, Vienna, Austria

This meeting will provide an opportunity to discuss the WHO guidelines on treatment of multidrug- and extensively drug-resistant tuberculosis (M/XDR-TB), and will support Member States in updating their national M/XDR-TB treatment policies based on the latest WHO recommendations. The meeting will offer practical support for the operationalization of the new guidelines.

The event will allow participants to update the following elements and bring them in line with WHO’s global recommendations:

  • regional policies
  • treatment strategies
  • regimens and drugs used for treatment.

The meeting will be webcast via WebEx and some participants will be connected via Skype. The link to the sessions will also be provided to National TB Control Programme managers, partners and observers in countries of the WHO European Region who cannot participate at the meeting.

rGLC/Europe is the advisory body for WHO/Europe on implementation of drug-resistant TB prevention, treatment and follow-up. Regular meetings of rGLC/Europe members are held online. WHO/Europe also organizes face-to-face meetings of the members and invites major stakeholders, with a view to ensuring transparency and accountability. WHO/Europe hosts the rGLC/Europe Secretariat.